|
1
|
Nadal A and Cardesa A: Molecular biology
of laryngeal squamous cell carcinoma. Virchows Arch. 442:1–7.
2003.PubMed/NCBI
|
|
2
|
Lionello M, Staffieri A and Marioni G:
Potential prognostic and therapeutic role for angiogenesis markers
in laryngeal carcinoma. Acta Otolaryngol. 132:574–582. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caicedo-Granados E, Beswick DM,
Christopoulos A, Cunningham DE, Razfar A, Ohr JP, Heron DE and
Ferris RL: Oncologic and functional outcomes of partial laryngeal
surgery for intermediate-stage laryngeal cancer. Otolaryngol Head
Neck Surg. 148:235–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mandemakers W, Abuhatzira L, Xu H,
Caromile LA, Hébert SS, Snellinx A, Morais VA, Matta S, Cai T,
Notkins AL and De Strooper B: Co-regulation of intragenic microRNA
miR-153 and its host gene Ia-2 β: Identification of miR-153 target
genes with functions related to IA-2β in pancreas and brain.
Diabetologia. 56:1547–1556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim TH, Kim YK, Kwon Y, Heo JH, Kang H,
Kim G and An HJ: Deregulation of miR-519a, 153 and 485-5p and its
clinicopathological relevance in ovarian epithelial tumours.
Histopathology. 57:734–743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Q, Sun Q, Zhang J, Yu J, Chen W and
Zhang Z: Downregulation of miR-153 contributes to
epithelial-mesenchymal transition and tumor metastasis in human
epithelial cancer. Carcinogenesis. 34:539–549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan Y, Du W, Wang Y, Xu C, Wang J, Zhang
Y, Wang H, Ju J, Zhao L, Wang Z, et al: Suppression of AKT
expression by miR-153 produced anti-tumor activity in lung cancer.
Int J Cancer. 136:1333–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Pickard K, Jenei V, Bullock MD,
Bruce A, Mitter R, Kelly G, Paraskeva C, Strefford J, Primrose J,
et al: MiR-153 supports colorectal cancer progression via
pleiotropic effects that enhance invasion and chemotherapeutic
resistance. Cancer Res. 73:6435–6447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Erickson HS, Albert PS, Gillespie JW,
Wallis BS, Rodriguez-Canales J, Linehan WM, Gonzalez S, Velasco A,
Chuaqui RF and Emmert-Buck MR: Assessment of normalization
strategies for quantitative RT-PCR using microdissected tissue
samples. Lab Invest. 87:951–962. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dweep H, Gretz N and Sticht C: MiRWalk
database for miRNA-target interactions. Methods Mol Biol.
1182:289–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nandan MO, Chanchevalap S, Dalton WB and
Yang VW: Kruppel-like factor 5 promotes mitosis by activating the
cyclin B1/Cdc2 complex during oncogenic Ras-mediated
transformation. FEBS Lett. 579:4757–4762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Wen JK, Dong LH, Zheng B and Han M:
Kruppel-like factor (KLF) 5 mediates cyclin D1 expression and cell
proliferation via interaction with c-Jun in Ang II-induced VSMCs.
Acta Pharmacol Sin. 31:10–18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bao B, Rodriguez-Melendez R and Zempleni
J: Cytosine methylation in miR-153 gene promoters increases the
expression of holocarboxylase synthetase, thereby increasing the
abundance of histone H4 biotinylation marks in HEK-293 human kidney
cells. J Nutr Biochem. 23:635–639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghaleb AM, Nandan MO, Chanchevalap S,
Dalton WB, Hisamuddin IM and Yang VW: Kruppel-like factors 4 and 5:
The yin and yang regulators of cellular proliferation. Cell Res.
15:92–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dong JT and Chen C: Essential role of KLF5
transcription factor in cell proliferation and differentiation and
its implications for human diseases. Cell Mol Life Sci.
66:2691–2706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu R, Dong JT and Chen C: Role of KLF5 in
hormonal signaling and breast cancer development. Vitam Horm.
93:213–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bialkowska AB, Liu Y, Nandan MO and Yang
VW: A colon cancer-derived mutant of Kruppel-like factor 5 (KLF5)
is resistant to degradation by glycogen synthase kinase 3β (GSK3β)
and the E3 ubiquitin ligase F-box and WD repeat domain-containing
7α (FBW7 α). J Biol Chem. 289:5997–6005. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frigo DE, Sherk AB, Wittmann BM, Norris
JD, Wang Q, Joseph JD, Toner AP, Brown M and McDonnell DP:
Induction of Kruppel-like factor 5 expression by androgens results
in increased CXCR4-dependent migration of prostate cancer cells in
vitro. Mol Endocrinol. 23:1385–1396. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X, Liu X, Xu Y, Liu J, Xie M, Ni W and
Chen S: KLF5 promotes hypoxia-induced survival and inhibits
apoptosis in non-small cell lung cancer cells via HIF-1α. Int J
Oncol. 45:1507–1514. 2014.PubMed/NCBI
|
|
23
|
Nakaya T, Ogawa S, Manabe I, Tanaka M,
Sanada M, Sato T, Taketo MM, Nakao K, Clevers H, Fukayama M, et al:
KLF5 regulates the integrity and oncogenicity of intestinal stem
cells. Cancer Res. 74:2882–2891. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu N, Gu L, Findley HW, Chen C, Dong JT,
Yang L and Zhou M: KLF5 Interacts with p53 in regulating survivin
expression in acute lymphoblastic leukemia. J Biol Chem.
281:14711–14718. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Q, Dong Z, Zhou F, Cai X, Gao Y and
Wang LW: Kruppel-like factor 5 promotes lung tumorigenesis through
upregulation of Sox4. Cell Physiol Biochem. 33:1–10. 2014.
View Article : Google Scholar : PubMed/NCBI
|
